Overview

Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects

Status:
Completed
Trial end date:
2016-05-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antiviral effect, as measured by viral titer in nasal secretions in adults with acute uncomplicated seasonal influenza A following administration of VX-787.
Phase:
Phase 2
Details
Lead Sponsor:
Janssen Research & Development, LLC
Vertex Pharmaceuticals Incorporated
Collaborator:
Janssen Pharmaceuticals
Treatments:
Oseltamivir